申请人:——
公开号:US20040006121A1
公开(公告)日:2004-01-08
This invention provides a total synthesis of Merrillactone and Merrilactone analogues having the structure
1
wherein Z is O or >N—X, where X is H, straight or branched substituted or unsubstituted alkyl, alkenyl or alkynyl, or acyl, carbamoyl, cycloalkyl, aryl, heterocycloalkyl, heteroaryl, aralkyl, amino, alkyl amino, or dialkyl amino;
wherein each of R
1
and R
2
is H or R
1
and R
2
together are ═O;
wherein each of R
3
and R
4
is H or R
3
and R
4
together are ═O;
wherein each of R
5
and R
6
is, independently, H, alkyl, aralkyl, or aryl;
wherein each of R
7
and R
8
is, independently, H or OR
14
, where R
14
is alkyl or —C(O)—R
15
,
where R
15
is H, —CH
2
R
16
, —CHR
16
R
16
, —CR
16
R
17
R
16
, —OR
16
, alkenyl or alkynyl, cycloalkyl, aryl, heterocycloalkyl, heteroaryl, aralkyl, amino, alkyl amino, or dialkyl amino,
wherein each R
16
is straight or branched, substituted or unsubstituted alkyl, alkenyl or alkynyl, cycloalkyl, aryl, heterocycloalkyl, heteroaryl, aralkyl, or amino; and
wherein R
17
is straight or branched, unsubstituted alkyl, alkenyl or alkynyl, cycloalkyl, aryl, heterocycloalkyl, heteroaryl, aralkyl, or amino,
or wherein R
7
and R
9
together are >O;
wherein each of R
9
and R
10
is, independently, H, alkyl, OH, or OR
13
, where R
13
is an alkyl, an acyl, or an amide, or R
9
and R
10
together are ═CH
2
,
or wherein R
8
and R
10
together are >O;
wherein if one of R
7
or R
8
and one of R
9
or R
10
is absent, a double bond is formed as indicated by the broken line; and
wherein each of R
11
and R
12
is, independently, H, OH, or OR
13
, where R
13
is an alkyl, an acyl, or an amide, or R
11
and R
12
together are ═O,
or wherein R
12
and R
10
together are >O, including intermediates in the synthesis.
这项发明提供了Merrillactone和Merrilactone类似物的全合成,其结构如下:其中Z为O或>N—X,其中X为H,直链或支链取代或未取代的烷基,烯基或炔基,或酰基,氨基,环烷基,芳基,杂环烷基,杂芳基,芳基烷基,氨基,烷基氨基或二烷基氨基;其中R1和R2中的每一个为H或R1和R2一起为═O;其中R3和R4中的每一个为H或R3和R4一起为═O;其中R5和R6中的每一个独立地为H,烷基,芳基烷基或芳基;其中R7和R8中的每一个独立地为H或OR14,其中R14为烷基或—C(O)—R15,其中R15为H,—CH2R16,—CHR16R16,—CR16R17R16,—OR16,烯基或炔基,环烷基,芳基,杂环烷基,杂芳基,芳基烷基,氨基,烷基氨基或二烷基氨基,其中每个R16为直链或支链,取代或未取代的烷基,烯基或炔基,环烷基,芳基,杂环烷基,杂芳基,芳基烷基或氨基;其中R17为直链或支链,未取代的烷基,烯基或炔基,环烷基,芳基,杂环烷基,杂芳基,芳基烷基或氨基,或其中R7和R9一起为>O;其中R9和R10中的每一个独立地为H,烷基,羟基或OR13,其中R13为烷基,酰基或酰胺,或R9和R10一起为═CH2;或其中R8和R10一起为>O;如果R7或R8中的一个和R9或R10中的一个缺失,则形成如虚线所示的双键;其中R11和R12中的每一个独立地为H,羟基或OR13,其中R13为烷基,酰基或酰胺,或R11和R12一起为═O;或其中R12和R10一起为>O,包括合成中间体。